Published in TB and Outbreaks Week, October 23rd, 2001
Barr officials said that the contract provides $17.4 million to support Phase I development, and $18 million to support Phase II and Phase III clinical studies and the filing of the biological license applications. Following successful approval, Barr would manufacture the vaccines under contract to the government specifically for dispensing to the armed forces.
"We are excited about the opportunity to work with Walter Reed Army Institute of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.